Psych Disorders May Reduce Response to CGRPs for Migraine Psych Disorders May Reduce Response to CGRPs for Migraine

Patients with migraine are less likely to respond to the new CGRP monoclonal antibody preventive treatments, if they have certain psychiatric disorders, new research shows.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Neurology & Neurosurgery Source Type: news